SubsidieMeesters logoSubsidieMeesters
ProjectenRegelingenAnalyses

Bioactive reinforcing bioink for hybrid bioprinting of implantable bone

The project aims to develop 'BioForceInk,' a bioactive bioink for hybrid 3D bioprinting of vascularized bone implants, enhancing mechanical strength and biological functionality for clinical applications.

Subsidie
€ 150.000
2024

Projectdetails

Introduction

3D bioprinting is an emerging technique that offers promise for fabricating implantable tissues. Despite significant advancements, the field struggles to replicate the mechanical robustness and biological complexity of native tissues, particularly in applications requiring high mechanical strength such as bone.

Project Overview

This proposal introduces 'BioForceInk,' a bioactive reinforcing bioink designed for direct bioprinting alongside a cell-laden hydrogel within a cell-conductive environment. The microparticle-based bioink is printable at room temperature and solidifies at 37°C, forming a stiff, porous scaffold within the construct.

Preliminary Studies

Our preliminary studies demonstrated its excellent printability, mechanical properties, and osteoconductive capabilities in a hybrid bioprinting context.

Objectives

To enhance vascularized bone differentiation in vitro and support bioprinted implant integration and bone recovery in vivo, the bioink will be enriched with osteogenic and vasculogenic factors.

  1. Develop the growth factor-loaded BioForceInk.
  2. Utilize it for creating vascularized bone implants by hybrid bioprinting in tandem with cell-laden soft bioink.
  3. Evaluate the regenerative potential of the bioprinted vascularized bone implants in a critical-size bone loss model.
  4. Test the technology with industrial partners and prepare it for commercialization by the end of the project.

Innovation and Potential

BioForceInk offers a unique combination of mechanical support and biological activity that facilitates the single-step fabrication of physiologically relevant bone implants. This innovation has the potential to significantly narrow the gap between bioprinting technology and clinical application, contributing to the development of personalized, mechanically robust, and biologically functional bone implants.

Future Applications

With its tunable properties, BioForceInk could be further adapted for bioprinting of various tissues, reflecting its broad potential across the field.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 150.000
Totale projectbegroting€ 150.000

Tijdlijn

Startdatum1-9-2024
Einddatum28-2-2026
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • TECHNION - ISRAEL INSTITUTE OF TECHNOLOGYpenvoerder

Land(en)

Israel

Inhoudsopgave

European Research Council

Financiering tot €10 miljoen voor baanbrekend frontier-onderzoek via ERC-grants (Starting, Consolidator, Advanced, Synergy, Proof of Concept).

Bekijk regeling

Vergelijkbare projecten binnen European Research Council

ProjectRegelingBedragJaarActie

Human based bioinks to engineer physiologically relevant tissues

HumanINK aims to validate human-based bioinks for 3D bioprinting, creating advanced cell culture environments to enhance drug development and reduce reliance on animal testing.

ERC Proof of...€ 150.000
2022
Details

A novel support material for 3D bioprinting and post-printing tissue growth: Print and Grow

The "Print and Grow" project aims to enhance 3D bioprinting stability and viability of tissue constructs through a novel microgel support, optimizing for diverse tissue types and in vivo applications.

ERC Proof of...€ 150.000
2022
Details

A 3D-printable biomimetic bone regeneration material

PRIOBONE aims to validate a novel 3D-printable, bone-mimetic material for critical-size bone defects, offering a customizable, cost-effective solution to improve healing outcomes.

ERC Proof of...€ 150.000
2024
Details

4D bioprinting shape-morphing tissues using phototunable supramolecular hydrogels

morphoPRINT aims to develop a dynamic hydrogel platform for bioprinted tissues that enables programmable shape-morphing, facilitating the creation of functional organs through controlled volumetric growth.

ERC Starting...€ 1.499.906
2023
Details

Self-feeding implants to improve and accelerate tissue healing using nutritional nanoparticles

The NutriBone project aims to develop a patented self-feeding bone implant that enhances long-term viability and reduces failure rates for large bone defects through glycogen-based glucose release.

ERC Proof of...€ 150.000
2024
Details
ERC Proof of...

Human based bioinks to engineer physiologically relevant tissues

HumanINK aims to validate human-based bioinks for 3D bioprinting, creating advanced cell culture environments to enhance drug development and reduce reliance on animal testing.

ERC Proof of Concept
€ 150.000
2022
Details
ERC Proof of...

A novel support material for 3D bioprinting and post-printing tissue growth: Print and Grow

The "Print and Grow" project aims to enhance 3D bioprinting stability and viability of tissue constructs through a novel microgel support, optimizing for diverse tissue types and in vivo applications.

ERC Proof of Concept
€ 150.000
2022
Details
ERC Proof of...

A 3D-printable biomimetic bone regeneration material

PRIOBONE aims to validate a novel 3D-printable, bone-mimetic material for critical-size bone defects, offering a customizable, cost-effective solution to improve healing outcomes.

ERC Proof of Concept
€ 150.000
2024
Details
ERC Starting...

4D bioprinting shape-morphing tissues using phototunable supramolecular hydrogels

morphoPRINT aims to develop a dynamic hydrogel platform for bioprinted tissues that enables programmable shape-morphing, facilitating the creation of functional organs through controlled volumetric growth.

ERC Starting Grant
€ 1.499.906
2023
Details
ERC Proof of...

Self-feeding implants to improve and accelerate tissue healing using nutritional nanoparticles

The NutriBone project aims to develop a patented self-feeding bone implant that enhances long-term viability and reduces failure rates for large bone defects through glycogen-based glucose release.

ERC Proof of Concept
€ 150.000
2024
Details

Vergelijkbare projecten uit andere regelingen

ProjectRegelingBedragJaarActie

Revolutionary silk-based bioink for 3D printing of ex vivo bone marrow models to advance drug development and personalized medicine

The SILKink project aims to develop a silk-based bioink for 3D printing bone marrow tissue models to enhance stem cell culture and advance drug development and personalized medicine.

EIC Transition€ 2.494.687
2023
Details

Better Bioprinting by Light-sheet Lithography

B-BRIGHTER aims to develop a novel high-speed bioprinting technology for creating complex engineered tissues, enhancing drug testing and therapeutic applications while fostering healthcare innovation.

EIC Transition€ 2.093.331
2022
Details

PRInted Symbiotic Materials as a dynamic platform for Living Tissues production

PRISM-LT aims to develop a flexible bioprinting platform using hybrid living materials to enhance stem cell differentiation with engineered helper cells for biomedical and food applications.

EIC Pathfinder€ 2.805.403
2022
Details

Ceramic paste for 3D-printable bone implants

Z3DLABS en Delft Solids Solutions ontwikkelen een 3D printbare keramische pasta voor patiëntspecifieke, bio-compatibele botimplantaten met een langere levensduur en lagere behandelkosten.

Mkb-innovati...€ 195.510
2020
Details

High-throughput ultrasound-based volumetric 3D printing for tissue engineering

SONOCRAFT aims to revolutionize myocardial cell construct bioprinting by combining rapid volumetric printing with ultrasonic manipulation to create functional cardiac models for drug testing and disease research.

EIC Pathfinder€ 2.999.625
2025
Details
EIC Transition

Revolutionary silk-based bioink for 3D printing of ex vivo bone marrow models to advance drug development and personalized medicine

The SILKink project aims to develop a silk-based bioink for 3D printing bone marrow tissue models to enhance stem cell culture and advance drug development and personalized medicine.

EIC Transition
€ 2.494.687
2023
Details
EIC Transition

Better Bioprinting by Light-sheet Lithography

B-BRIGHTER aims to develop a novel high-speed bioprinting technology for creating complex engineered tissues, enhancing drug testing and therapeutic applications while fostering healthcare innovation.

EIC Transition
€ 2.093.331
2022
Details
EIC Pathfinder

PRInted Symbiotic Materials as a dynamic platform for Living Tissues production

PRISM-LT aims to develop a flexible bioprinting platform using hybrid living materials to enhance stem cell differentiation with engineered helper cells for biomedical and food applications.

EIC Pathfinder
€ 2.805.403
2022
Details
Mkb-innovati...

Ceramic paste for 3D-printable bone implants

Z3DLABS en Delft Solids Solutions ontwikkelen een 3D printbare keramische pasta voor patiëntspecifieke, bio-compatibele botimplantaten met een langere levensduur en lagere behandelkosten.

Mkb-innovatiestimulering Topsectoren R&D Samenwerking
€ 195.510
2020
Details
EIC Pathfinder

High-throughput ultrasound-based volumetric 3D printing for tissue engineering

SONOCRAFT aims to revolutionize myocardial cell construct bioprinting by combining rapid volumetric printing with ultrasonic manipulation to create functional cardiac models for drug testing and disease research.

EIC Pathfinder
€ 2.999.625
2025
Details

SubsidieMeesters logoSubsidieMeesters

Vind en verken subsidieprojecten in Nederland en Europa.

Links

  • Projecten
  • Regelingen
  • Analyses

Suggesties

Heb je ideeën voor nieuwe features of verbeteringen?

Deel je suggestie
© 2025 SubsidieMeesters. Alle rechten voorbehouden.